Drug intelligence / Profile preview

Biovanta

Development stage
Unknown
Lead developer
Applied Biological Laboratories
Modality
Small Molecules
Administration
Oral
01

Overview

**Biovanta** is an Applied Biological Laboratories over-the-counter respiratory-symptom product brand that includes throat sprays, lozenges, tablets, and multi-product kits. Drug-containing Biovanta formulations use acetylsalicylic acid as an NSAID analgesic; for example, the Dual Action throat spray contains 6 mg aspirin per spray and is labeled for temporary relief of minor aches and pains associated with sore throat. Some formulations also contain menthol as an antitussive, while lactoferrin, lysozyme, aloe, and related ingredients are listed as inactive ingredients or dietary-supplement components depending on the product. The brand has been studied in a completed randomized common-cold trial. Biovanta products should not be represented as FDA-approved treatments for COVID-19; FDA issued a March 24, 2022 warning letter concerning unapproved and misbranded COVID-19 claims for certain Biovanta products. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ad34559a-1a0f-693d-e053-2995a90ae70a))

Brand names
Biovanta
Other names
aspirin throat sprayMIC spray with aspirin
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on Biovanta.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biovanta.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call